You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AML

Showing 1 - 25 of 2,908
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AML, Adult, Minimal Residual Disease Trial in Guangzhou (chidamide and azacitidine)

Not yet recruiting
  • AML, Adult
  • Minimal Residual Disease
  • chidamide and azacitidine
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Sep 27, 2023

AML, Adult Trial (Biological characterization of AML with MECOM or atypical 3q26 rearrangements)

Not yet recruiting
  • AML, Adult
  • Biological characterization of AML with MECOM or atypical 3q26 rearrangements
  • (no location specified)
Apr 21, 2023

Assessment of Geriatric Evaluations Impact on New AML Guidance

Not yet recruiting
  • AML, Adult
    • Philadelphia, Pennsylvania
      Abramson Cancer Center at University of Pennsylvania
    Jun 12, 2023

    AML Trial in Berne (Image-based ex-vivo drug screening platform (pharmacoscopy))

    Recruiting
    • AML
    • Image-based ex-vivo drug screening platform (pharmacoscopy)
    • Berne, Switzerland
      Departement of Medical Oncology, University Hospital Berne
    Feb 8, 2023

    Acute Myeloid Leukemia in Children Trial (Standard Intervention, Investigational Intervention)

    Not yet recruiting
    • Acute Myeloid Leukemia in Children
    • Standard Intervention
    • Investigational Intervention
    • (no location specified)
    Aug 8, 2023

    AML/MDS, Acute Myeloid Leukemia, MDS Trial (Danvatirsen, Danvatirsen + Venetoclax)

    Not yet recruiting
    • AML/MDS
    • +2 more
    • (no location specified)
    Aug 14, 2023

    AML, Adult Trial (STI-8591)

    Not yet recruiting
    • AML, Adult
    • (no location specified)
    Jul 12, 2023

    Core Binding Factor Acute Myeloid Leukemia, KIT Mutation-Related Tumors Trial in Suzhou (Avapritinib)

    Recruiting
    • Core Binding Factor Acute Myeloid Leukemia
    • KIT Mutation-Related Tumors
    • Suzhou, Jiangsu, China
      First Affiliated Hospital of Soochow University
    Apr 7, 2023

    AML, Adult Trial (Pharmacoscopy, Clinical standard-of-care (physician's choice))

    Not yet recruiting
    • AML, Adult
    • Pharmacoscopy
    • Clinical standard-of-care (physician's choice)
    • (no location specified)
    Nov 20, 2023

    Essential Hypertension Trial (AZM X mg + AML Y mg, AZM X mg + AML Y' mg, AZM X' mg + AML Y mg)

    Not yet recruiting
    • Essential Hypertension
    • AZM X mg + AML Y mg
    • +7 more
    • (no location specified)
    May 25, 2022

    Relapsed/Refractory AML Trial in Suzhou (Selinexor, Homoharringtonine, Cytarabine)

    Not yet recruiting
    • Relapsed/Refractory AML
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Mar 28, 2023

    Acute Myeloid Leukemia Trial (MCBC regimen, Bu/Cy regimen)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • MCBC regimen
    • Bu/Cy regimen
    • (no location specified)
    Nov 13, 2023

    Acute Myeloid Leukemia (AML) Trial in Nantes (Siltuximab)

    Not yet recruiting
    • Acute Myeloid Leukemia (AML)
    • Nantes, France
      CHU de Nantes
    Jan 24, 2023

    Immunophenotyping of Blast Cells and Immune Effector Cells in

    Completed
    • Leukemia
    • Blood and Marrow sample
    • Marseille, France
      Assistance Publique - Hopitaux de Marseille
    Jan 23, 2023

    AML Trial in Beijing (IM23)

    Completed
    • AML
    • Beijing, China
      Xian Lu
    Jan 18, 2023

    Acute Myeloid Leukemia (AML) Trial in Nantes (Tocilizumab)

    Active, not recruiting
    • Acute Myeloid Leukemia (AML)
    • Nantes, France
      CHU of Nantes
    Dec 16, 2022

    AML Including AML de Novo and AML Secondary to MDS, DLBCL Trial (Birabresib Dose 20 mg)

    Terminated
    Has Results
    • AML Including AML de Novo and AML Secondary to MDS
    • DLBCL
    • Birabresib Dose 20 mg
    • (no location specified)
    Aug 23, 2022

    MDS, AML Trial in Bronx (Venetoclax, Decitabine)

    Recruiting
    • MDS
    • AML
    • Bronx, New York
      Montefiore Medical Center
    Jul 22, 2022

    AML, Adult Trial in Berne (HDM201, Midostaurin)

    Terminated
    • AML, Adult
    • Berne, Switzerland
      Departement of Medical Oncology, University Hospital Berne
    Oct 3, 2022

    CBFA2T3-GLIS2-positive Acute Myeloid Leukemia, AML, Childhood, Relapsed Pediatric AML Trial (ELU001)

    Not yet recruiting
    • CBFA2T3-GLIS2-positive Acute Myeloid Leukemia
    • +3 more
    • (no location specified)
    Nov 14, 2022

    Acute Myeloid Leukemia Trial (ABBV-787)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • (no location specified)
    Sep 29, 2023

    Acute Myeloid Leukemia Trial (Azacitidine, Donor lymphocyte infusion, Camrelizumab)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • (no location specified)
    Mar 15, 2023

    AML, Acute Myeloid Leukemia Trial in Boston (DREAMLAND, CERENA)

    Not yet recruiting
    • AML
    • Acute Myeloid Leukemia
    • DREAMLAND
    • CERENA
    • Boston, Massachusetts
      Massachusetts General Hospital
    Aug 12, 2022

    AML Trial in Wuhan (CAR--?dT cells)

    Recruiting
    • AML
    • CAR--γδT cells
    • Wuhan, Hubei, China
      Tongji Hospital
    May 24, 2022

    Acute Myeloid Leukemia Trial in Baltimore (Decitabine, talazoparib)

    Active, not recruiting
    Has Results
    • Acute Myeloid Leukemia
    • Baltimore, Maryland
      University of Maryland Greenebaum Comprehensive Cancer Center
    May 31, 2022